medline.ch Gynäkologie

	Patient-reported distress and correlates while on adjuvant endocrine therapy following breast cancer treatment among post-menopausal women: a group-based trajectory model analysis. Support Care Cancer Gavin KL, Tiegs J, Winn AN, Makris V, Neuner JM, Flynn KE. PMID: 42348017 [PubMed - indexed for MEDLINE]
	HPV in breast cancer: prevalence and comparison with healthy tissue-a systematic review and meta-analysis. Cancer Causes Control de Souza Wagner PH, Matheus GTFU, Menegat BLRS, Menegat ALRS, Ribeiro DM, de Moraes FCA. PMID: 42348000 [PubMed - indexed for MEDLINE]
	Physics-informed patient-specific calibration for monocular visual-based dose reconstruction in breast cancer radiotherapy. Med Phys Deng Y, Wang X, Chen R. PMID: 42347841 [PubMed - indexed for MEDLINE]
	Machine Learning-Based Classification of BI-RADS 4 and BI-RADS 5 Microcalcifications in Mammography Combined with DCE-MRI for Malignant-Benign Discrimination. Tomography Ünal S, Aç. PMID: 42347143 [PubMed - indexed for MEDLINE]
	Image Quality Assessment of Diffusion-Weighted Imaging (DWI) and Its Impact on Apparent Diffusion Coefficient (ADC) as a Quantitative Imaging Biomarker for Predicting Response to Neoadjuvant Chemotherapy in High-Risk Early Breast Cancer. Tomography Li W, Wilmes LJ, Carmona-Bozo J, Le NN, Chung M, Gibbs JE, Onishi N, Price E, Joe BN, Kornak J, Chenevert TL, Malyarenko D, Bolan PJ, Partridge SC, Hylton NM. PMID: 42347142 [PubMed - indexed for MEDLINE]
	Terahertz Imaging for Breast Cancer Detection in Animal Models: A Literature Review with Narrative Synthesis. Med Sci (Basel) Ni, Matasariu DR, Matei MC, Cazacu A, Tamba BI, Apostol DC, Borcia C, Uritu CM, Ciorpac M, Ursache A, Mandici CE, David C, D, Baican M, Ghizdov, Grierosu IC, . PMID: 42346862 [PubMed - indexed for MEDLINE]
	PAP Versus DIEP Flap Breast Reconstruction: Current Evidence and the Unresolved Question of Timing and Oncologic Safety-A Narrative Review. Med Sci (Basel) Muntean MV, Ilie, Gâta VA, , Pop IC, Or, Filip GG, Pintican R, Antone NZ, Achima. PMID: 42346834 [PubMed - indexed for MEDLINE]
	Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study. Curr Oncol Seyyar M, Kalem A, Sali M, Karabu, Sahin TK, Di, Türkel A, Karadurmu, , Avc, Bilgetekin I, Köse Baytemur N, Uguztemur E, Oflazo, Gür HB, Hac, Akku, Topalo, Bayramgil A, Dülgar Kaya Ö, Yaz, , Akay S, Majidova N, Guliyev M, Alan Ö, Gülcü S, Eren T, , Güren AK, Köstek O, Ünlü A, Ozturk B, Ayd, Safarov S, Do, Tükenmez MA, Demir T, , Erdemo, Keskin Uzundere F, Bütün O, Karabulut B, Uzun M, Bayda, Karaman E, Arak H, Ekinci F, Aykan MB, Ertürk , Guven DC, Deligönül A, Karaçin C, Ate, , Ye, Aksoy S, Kö, Ökten , Y, Çabuk D. PMID: 42346265 [PubMed - indexed for MEDLINE]
	Development and Preliminary Validation of a Tool to Assess Barriers and Facilitators to Participation in Adjuvant Endocrine Therapy Switch Trials. Curr Oncol Belloni S, Tiberio P, Mencaglia E, Brera AS, Giacon C, Benvenuti C, Jacobs F, Gaudio M, Torrisi R, Santoro A, Caruso R, Arrigoni C, Zambelli A, De Sanctis R. PMID: 42346261 [PubMed - indexed for MEDLINE]
	Excessive Tearing and Lacrimal and Canalicular Blockage Secondary to Docetaxel in Breast Cancer Patients in the Metastatic and Adjuvant Settings. Curr Oncol Pfeiffer ML, Esmaeli B. PMID: 42346259 [PubMed - indexed for MEDLINE]
	Domain-Specific Computational, Functional and Structural Methods Enable Interpretation of BRCA1 BRCT Variants of Uncertain Significance. Curr Oncol Torretto GC, Martin MD, Islam K, Archer NE, Feilotter HE, Davey SK. PMID: 42346254 [PubMed - indexed for MEDLINE]
	One Surgery, Two Solutions: A Systematic Review of Combined Autologous Breast Reconstruction and Lymphatic Surgery. Curr Oncol Lingenheil I, Radacher L, Machens HG, Mayr-Riedler M, Seidenstücker K, Broer NP, Grünherz L. PMID: 42346238 [PubMed - indexed for MEDLINE]
	Regional Variations in Guideline Concordance for Women with Triple-Negative and HER2+ Breast Cancer in Nova Scotia. Curr Oncol Mayo A, Stewart H, Li T, Penny C, Hemsworth R, Drohan A, Neumann K, Gala-Lopez B, Spence RT, Knapp G. PMID: 42346232 [PubMed - indexed for MEDLINE]
	Temporal Patterns of Breast Cancer-Related Sickness Absence and Social Insurance Expenditures Among Women in Poland, 2020-2024: A Nationwide Registry-Based Study. Curr Oncol Winciunas PA, Grudzi, Mazurek A, S, Zgliczy, Jankowski M. PMID: 42346226 [PubMed - indexed for MEDLINE]
	Association Between Endocrine Therapy and Fracture Risk in Women with Breast Cancer in Germany-A Retrospective Cohort Study. Curr Oncol Kostev K, Peters M, Sievert H, Kalder M. PMID: 42346222 [PubMed - indexed for MEDLINE]
	Pregnancy Outcomes After in Utero Exposure to Immune Checkpoint Inhibitors. Curr Oncol Bou Zerdan M, Kfoury B, Aoun E, Hmaidan SD, Wilke RN, How JA, Woodard TL, Soliman PT, McKenzie LJ. PMID: 42346218 [PubMed - indexed for MEDLINE]
	Long-Term Side Effects of Breast Cancer Treatments: A Systematic Review. Breast J Babaee E, Soheyli M, Nafissi N. PMID: 42345555 [PubMed - indexed for MEDLINE]
	Human cytomegalovirus at the maternal-fetal interface: an overview of pathogenesis, defence, and interventions. Clin Sci (Lond) Noor M, Aiken CE, Poole E, McGovern N. PMID: 42345277 [PubMed - indexed for MEDLINE]
	Temporal Hematologic Alterations in Women Receiving Pharmacotherapy for Breast Cancer: A Prospective Analysis. Asian Pac J Cancer Prev Sutanto H, Savitri M, Ashariati A, Hendarsih E, Romadhon PZ, Diansyah MN, Amrita PNA, Bintoro SUY. PMID: 42345180 [PubMed - indexed for MEDLINE]
	Combined Diagnostic Utility of Serum CA15-3 and Routine Hematological Indicators for Breast Cancer Differentiation in an Iraqi Cohort. Asian Pac J Cancer Prev Mohaibes MJ, Al-Khafaji M, Muhaibes F. PMID: 42345174 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 282864

Seite 1 von 14144

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung